Lackey Lab Journal Club – January Week 3

1/22/2021 – We discussed Yu et al.‘s recently published paper suggesting that RNA structural intermediates may be recognized by RNA processing machinery and that the transitional landscape of folding should be considered for regulation and function from the Lucks lab. Realistic molecular dynamic simulation of RNA molecules remains difficult, however, simulations can provide insight into the biology of RNA structure. Yu, et al.’s paper addresses some very tricky questions on co-transcriptional folding and how structures evolve during transcript to result in their final mature form. The R2D2 (reconstructing RNA dynamics from data) method uses experimental SHAPE data during impaired transcription to capture structures of progressively longer transcripts. The authors took this to the next step and performed molecular dynamic simulations on these structural stages. They delve deep into the maturation of the SRP RNA. The highlight I took from this paper is that key nucleotides that influence the final RNA structure may not be those that form a long hairpin, but the nucleotides that stabilize or destabilize intermediary structures. More work is needed to understand how the lessons from SRP apply to other RNAs and how to identify key nucleotides. In particular, I’d be interested in learning more about the conservation of nucleotides that participate in intermediary structures and whether variants in intermediary positions are associated with human disease.

Upcoming (1/29/2021) – First data presentation in the lab! Luke Hatfield will present an overview of his projects since he joined in early December.

Lackey Lab Journal Club – January Week 2

1/15/2021 – We read Marinus et al.‘s publication on developing novel SHAPE reagents to probe cellular RNA structure and improve signal-to-noise ratio in structural data from the Incarnato lab. There are a variety of RNA secondary structure probes, but all have caveats. For example, dimethyl sulfate (DMS) is highly reactive and easily penetrates cell membranes, but it only reacts well with A and C nucleotides (and it is highly toxic!). Most sensitive chemical probes like 1M7 and NIA result in better structure information from all four bases, but do not easily penetrate cell membranes and require extensive effort to develop good signal from background noise. Marinus et al. address this problem by synthesizing additional reagents based on NIA. The best of the new reagents, 2-aminopyrimidine-3-carboxylic acid imidazolide (2A3), only differs from NIA by replacing a methyl group with an amino group. However, this subtle difference makes this molecule more reactive with RNA, dramatically improving the signal-to-noise ratio, and allows the molecule to penetrate cell membranes more effectively. I would have liked to see the comparison with 5NIA, which I have used in lab and can permeate some types of mammalian cells. However, I think an additional reagent that improves RNA secondary structure experimental data is extremely useful and hope to test it out soon!

Upcoming (1/22/2021) – We will discuss Yu et al.‘s publication suggesting that RNA structural intermediates may be recognized by RNA processing machinery and that the transitional landscape of folding should be considered for regulation and function. This paper was recently published from the Lucks lab.

Lackey Lab Journal Club – January Week 1

1/8/2021 – For our first meeting of 2021, we discussed Liu, et al.’s 2021 paper on the nuclear structurome from the Ding lab. The authors used Arabidopsis seedlings (dunked in RNA secondary structure chemical probing reagents) to develop RNA structures on cytoplasmic and nuclear RNAs. At the core of this paper is the idea that in vivo and in vitro RNA structures differ significantly and, by extension, that precursor mRNA and mature mRNA also have dramatically different structures. This would imply that the structures of mature mRNAs are not accurate representations for understanding RNA binding protein recognition, particularly in the context of splicing and alternative polyadenylation. The authors also support the ability of SHAPE reagents (NAI) to detect protein binding by comparing the reactivity of “deproteinized” RNAs to RNA protein complexes. By comparing the reactivity of the nuclear and cytoplasmic RNAs, Liu et al. detect a 2-nucleotide “structural motif” of unstructured RNA at the -1 and -2 positions around the 5′ splice site (within the exon). This “motif” corresponds with better recognition of the splice site and, in their experiments, are the only nucleotides required to be unpaired within the entire U1 snRNP recognition motif (spans -3 to +6). They did not detect a clear structural signal at the 3′ splice site, but did see an increase in single-stranded signal around the branch point. Likewise, strong polyadenylation signals have an overall high reactivity, suggested unpaired nucleotides. Is the difference between nuclear and cytoplasmic RNA structure due to protein binding differences between the two compartments? What the mechanism underlying dramatic structural changes? Is this an active process or inherent in the splicing transition where two exons form newly conjoined sequences that rearrange? I think the idea of RNAs with difference nuclear and cytoplasmic structures is intriguing. I’d like to see whether this concept and the 5′ splice site “structural motif” hold up humans.

Upcoming (1/15/2021) – We will discuss Marinus et al.‘s publication on novel SHAPE reagents with new abilities from the Incarnato lab!

Lackey Lab Journal Club – December Week 4

12/31/2020 – On the last day of 2020, we discussed Bubenik, et al.’s recent paper on deriving experimental RNA structure from low abundance transcripts (i.e. pre-cursor mRNAs) from the Berglund lab. We were particularly interested in the methods since we are working on a similar assay in our lab! Protocol-wise, Bubenik, et al., used standard chemical probing to fix RNA secondary structural information followed by probe hybridization to enrich for their desired target. We hope to learn from this publication and continue our work with similar, more high-throughput experiments to broadly understand intronic structure. Bubenik, et al., used a nice inducible system which over-expresses the RNA binding protein MBNL in a background with the endogenous MBNL protein eliminated, but endogenous MBNL transcript present. Defects in MBNL result in myotonic dystrophy and influence a specific set of alternatively spliced exons, including an exon within MBNL itself. This intron-exon junction within MBNL was the focus for structural and experimental studies in this paper. By controlling MBNL expression the authors could analyze RNA structure at the MBNL controlled splice site carefully. It would be very interesting to see the results of an eCLIP study in tandem with this probe hybridization structure work (such as we recently discussed in Corley, et al.). The structural results in the presence and absence of MBNL binding were not substantially different. This is consistent with the prevailing theme that RNA binding proteins easily interact, and even occasionally prefer, highly structured regions even though the specific nucleotides the proteins recognize are normally unpaired.

Upcoming (1/8/2021) – So many good papers to chose from…

Lackey Lab Journal Club – December Week 3

12/18/2020 – We discussed Mi Seul, et al.’s paper on AGO3 structure and activity (2017) from the Nakanishi lab, as well as a secondary paper on AGO3 activity (2020) with tyRNAs (tiny RNAs that are 14-17 nts long). My favorite part of the 2017 paper is the beautiful crystal structure of AGO3 + RNA the authors present. It is available on the pdb under the id 5VM9. In addition to their structural studies the authors also show compelling biochemical experiments demonstrating that the AGO3/microRNA complex is capable of cleaving target mRNAs under specific circumstances. Although AGO2 easily binds a wide variety of microRNAs and directs mRNA cleavage based on the microRNA/mRNA interaction, AGO3 was previously thought to be inactive. Any residual activity in AGO3 preparations in biochemical assays was thought to come from contaminating AGO2. By preparing and purifying AGO3 from insect cells the authors clearly show that AGO3 in complex with specific microRNAs can cleave mRNAs. In their most recent publication, Mi Seul, et al., expand their analysis and show that AGO3’s cleavage ability is influenced by the size of the small guide RNA. In comparison to AGO2, AGO3 poorly cleaves mRNAs when it is complexed with a typical microRNA (21-23nt long). However, AGO3 outperforms AGO2 when it is complexed with small guide RNAs (14 nt long). Interestingly the sequence of these cleavage inducing tiny RNAs (cityRNAs) is more important for cleavage than traditional microRNA guided cleavage by AGO2. It remains difficult to determine which mRNAs AGO3 activity might be relevant for, as these papers still only test a handful of microRNAs and similar cityRNAs. We look forward to learning more about the functions of other, less known members of the argonaute family.

Upcoming (12/31/2020): We are reading Bubenik, et al.’s recent paper on deriving RNA structure from low abundance transcripts (i.e. pre-cursor mRNAs) from the Berglund lab.

Lackey Lab Journal Club – December Week 2

12/11/20: We discussed Rafael de Cesaris Araujo Tavares, et al.’s paper from Anna Marie Pyle’s lab about RNA structure across SAR-CoV2. This paper was recently published in the Journal of Virology – The global and local distribution of RNA structure throughout the SARS-CoV-2 genome.

I knew that coronaviruses were very large. SARS-CoV-2 is nearly 30 kB long. I did not know that coronaviruses had such strong secondary structure profiles! The first figure in this paper comparing the overall structure of SARS-CoV-2 with the highly structured HCV and with human mRNA is very interesting. I have always been interested in comparing mRNAs, and mRNA regions (5’UTR, 3’UTR, etc), to one another for their degree of “structuredness”. My lab is particularly interested in mRNA structure, particularly within introns, so I’d be curious what kinds of values we see when precursor RNAs are calculated.

Tavares, et al., also show strong evidence for structure change when RNAs are removed from the genomic context to their mature form within SARS-CoV-2. Context dependent structure is very similar to what we expect when exonic mRNA sequences are spliced out of their precursor mRNA and into their mature mRNA form. Are certain types of RNA more dependent on context? How does this alter RNA binding protein interactions in the precursor and mature transcripts for SARS-CoV-2 and for human mRNAs?

The core of this paper is an analysis of in silico structure derived across this huge virus. I was surprised that the majority of predictions were performed on computationally derived structures and only at the end were previously published experimental structure values from chemical probing incorporated into structure prediction. Possibly this is because their experimental data is still at the pre-print stage. Although the structure profile of SARS-CoV-2 was roughly similar with and without experimental data there were significant differences. This is something that I would have liked the authors to expand upon more. Overall the meaning of differences between in silico, in vitro and in vivo derived structure models is unclear.

The authors discuss the concept of “RNA TADs”, which is the idea of long-range RNA structures that bring the genome together. Since SARS-CoV-2 has an RNA genome this is very similar to DNA TADs within the human genome that coordinate regions of chromatin accessibility, activation and ultimately transcriptional regulation. Although evidence for functional RNA TADs are not included in this paper this would be an interesting future avenue of research in RNA viral genome architecture.

Next week

12/18/20: We are reading Mi Seul, et al.’s paper on AGO3 structure and activity from the Nakanishi lab. Although initial publications concluded that only AGO2 of the four member human AGO family was able to cleave target mRNAs, the Nakanishi lab has shown that AGO3 contains a conserved catalytic core identical to AGO2 and is capable of cleaving target mRNAs under certain circumstances. Recently the Nakanishi lab published a follow-up paper on AGO3 activity with tyRNAs (tiny RNAs that are 14-17 nts long).

Lackey Lab Journal Club

There is so much amazing RNA research going on! We have a weekly journal club to talk about the latest publications. Here are the papers that we have been reading:

Upcoming 12/11/20: We are reading Rafael de Cesaris Araujo Tavares, et al.’s paper from Anna Marie Pyle’s lab about RNA structure across SAR-CoV2. This paper was recently published in the Journal of Virology – The global and local distribution of RNA structure throughout the SARS-CoV-2 genome.

12/4/20: We read Meredith Corley, et al.’s paper from Gene Yeo’s lab describing the fSHAPE protocol and its relevance. This paper was recently published in Molecular Cell – Footprinting SHAPE-eCLIP Reveals Transcriptome-wide Hydrogen Bonds at RNA-Protein Interfaces.

One interesting result we noticed in this paper was that RNA binding proteins generally interact with well structured regions (low Shannon entropy), but are more likely to directly contact accessible nucleotides within those structured regions. A question we would have liked to see more about in the discussion is how transcriptome-wide SHAPE protocols performed in the presence of proteins are influenced by protein protections and whether in-cell structure data is inaccurate or if eCLIP is necessary to see protein protection in standard SHAPE protocols.

RNA Society of South Carolina opens its (virtual) doors!

The RNA Society of South Carolina is a group of researchers interested in coming together to discuss progress in the field of RNA Biology. We decided to found the Society based on increasing interest in RNA regulation and function within the Center for Human Genetics and the Department of Genetics and Biochemistry. In the last decade many developments in RNA Biology have highlighted the importance of studying these molecules. Some of these developments include awareness of the key nature of non-coding regions within protein coding messenger RNAs and the identification of long non-coding RNAs, small regulatory RNAs, circular RNAs and many other RNA species. All human diseases are influenced by RNA and, as a Society, we are interested in disorders that arise from malfunctions in RNA Biology.

The RNA Society of South Carolina aims to stay current on new RNA research, collaborate together as a diverse, multi-disciplinary group and creatively pursue research in RNA Biology. We want the junior scientists in our laboratories to excel and our RNA Society of South Carolina meetings are designed to help trainees learn exciting new research and practice presenting their own research. If you are interested in being a part of the RNA Society of South Carolina, hosted by Clemson University, please contact the RNA S&R group and we will invite you to our meetings.

Our first official meeting is November 2, 2020 at 2pm. We are planning an virtual introductory meeting where RNA researchers have the opportunity to share their work and connect with other local RNA scientists. We are currently funded by the International RNA Society and Lexogen as an RNA Salon. Thank you for your support!

RNA Society
Lexogen

Alpha1 Foundation Investigators’ 2020 Meeting

The Alpha1 Investigators’ Meeting is on November 6th from 12-7pm. Dr. Lackey is presenting the results of her work on SERPINA1 post-transcriptional regulation.

Project title: Developing an accurate model of human α-1-antitrypsin protein expression through RNA structure and function

Investigator(s): L. Lackey, A. Coria, I. Jimenez-Ruiz, P. Grayeski, Z. Xu, J. Platig. P. Castaldi, A. Laederach

Objectives: Alpha1 anti-trypsin (A1AT) protein is produced from the SERPINA1 mRNA. Normally, A1AT inhibits the immune protease neutrophil elastase, but if A1AT does not function properly, over-active neutrophil elastase damages the lungs. This lung damage leads to a predisposition toward chronic obstructive pulmonary disease (COPD), particularly in the smoking population. Variants within SERPINA1 can cause low levels of A1AT or misfolded A1AT, which are associated with lung and liver disease. Little is known about variants within non-coding regions of SERPINA1 that impact A1AT expression. Regulatory elements within the 5’ Untranslated Region (UTR) of SERPINA1 mRNA impact A1AT expression, suggesting that non-coding variants are important for A1AT-associated disease predisposition. SERPINA1 also has around 1700 nucleotides of 3’UTR sequence, and the role of this region is not well characterized in terms of its effect on A1AT expression. Objectives are to identify non-coding variants that influence A1AT expression, test whether 3’UTR elements regulate A1AT expression and determine their mechanism of action.

Results: We identify two novel 3’UTR isoforms generated by alternative polyadenylation (APA) in the SERPINA1 mRNA. The short isoform, created by cleavage at a proximal site, is common and highly expressed in all tissues with SERPINA1 mRNA expression. The longer 3’UTR isoform is primarily expressed in the liver and represses protein expression in a reporter system by over two orders of magnitude. Patients with COPD have increased amounts of the long SERPINA1 3’UTR isoform compared to patients without COPD in lung primary tissue.

Conclusion: Regulatory elements within the non-coding UTRs of SERPINA1 influence A1AT expression. COPD patients have disproportionately high amounts of long 3’UTR SERPINA1 isoforms, which are likely not able to effectively translate the A1AT protein, possibly contributing to their disease. Additional studies are necessary to understand the pathway that leads to increased use of the distal APA site in individuals with COPD. Variants that impact regulatory elements alter A1AT expression and influence A1AT-associated disease, such as the published 5’UTR variant rs568223361, which is associated with decreased A1AT levels and lung disease.